Last Updated: August 9, 2026

Patent: 9,636,344

✉ Email this page to a colleague

Summary for Patent: 9,636,344

Title:	Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts
Abstract:	The present invention relates to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-- c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II): ##STR00001## or a tautomer, solvate or hydrate thereof; and to its use for the treatment of non-Hodgkin\'s lymphoma.
Inventor(s):	Peters; Jan-Georg (Solingen, DE), Militzer; Hans-Christian (Odenthal, DE), Muller; Hartwig (Velbert, DE)
Assignee:	Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:	14/990,350
Patent Claims:	see list of patent claims

Details for Patent 9,636,344

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	January 10, 1978	9,636,344	2036-01-07
Amgen Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234	June 01, 1989	9,636,344	2036-01-07
Amgen Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234		9,636,344	2036-01-07
Amgen Inc.	PROCRIT	epoetin alfa	Injection	103234		9,636,344	2036-01-07
Iovance Biotherapeutics Manufacturing Llc	PROLEUKIN	aldesleukin	For Injection	103293	May 05, 1992	9,636,344	2036-01-07
Amgen Inc.	NEUPOGEN	filgrastim	Injection	103353	February 20, 1991	9,636,344	2036-01-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.